Long COVID has impacted 3.2M Americans… and counting
“We do know for absolutely certain that there is a post-COVID syndrome. Anywhere from 25% to 35% — or more — have lingering symptoms.”
— Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Disease
In 2020, 21 science, post-viral disease and patient advocacy organizations came together to call for urgent government investment for Long COVID research. This successful effort laid the foundations of the Long COVID Alliance. Today, this network of patient-advocates, scientists, disease experts, and drug developers collaborate and share their collective knowledge to transform our understanding of post-viral illness.
- Submitted recommendations to Congress for Long COVID research investment in the 2020 COVID-19 Economic Relief Bill
- Helped secure $1.25 Billion for Long COVID research, diagnostics, and clinical trials at the NIH
- Shared research process recommendations and best practices with NIH
- Compiled list of top-tier Long COVID research proposals for NIH consideration
If you are a person looking for resources or patient support, please click here to send a message to our team.
Please understand that we provide general referrals and resources and are not able to respond to medical questions about specific doctors, treatments, or provide legal guidance.